Expression and Function of CXCL12/CXCR4/CXCR7 in Thyroid Cancer

Overview

Journal Int J Oncol

Specialty Oncology

Date 2016 Apr 16

PMID 27082011

Citations 29

Authors

Xiaoli Zhu

Qianming Bai

Yongming Lu

Yiqiong Lu

Linlin Zhu

Xiaoyan Zhou

Lijing Wu

Affiliations

Soon will be listed here.

Abstract

The contribution of CXCL12/CXCR4/CXCR7 axis to cancer progression has been increasingly recognized. However, its role in thyroid cancer development remains unclear. The present study aimed to examine the expression and function of CXCL12 and its receptors in thyroid cancer. The expression of CXCL12/CXCR4/CXCR7 in human tissue specimens of papillary, follicular, medullary, and anaplastic thyroid carcinoma, follicular adenoma, Hashimoto's thyroiditis and nodular goiter were examined by immunohistochemistry using a tissue microarray. CXCR4 and CXCR7 were over-expressed in human thyroid cancer cells K1 by transduction of recombinant lentivirus. The effect of overexpression of CXCR4 and CXCR7 on K1 cell proliferation and invasion and the molecular mechanism underlying the effect were investigated. CXCL12 was exclusively expressed in papillary thyroid carcinoma tissue but absent in other types of thyroid malignancies and benign lesions. CXCR7 was widely expressed in the endothelial cells of all types of malignancy but only occasionally detected in benign lesions. CXCR4 was expressed in 62.5% of papillary thyroid carcinoma tissue specimens and in 30-40% of other types of malignancy, and it was either absent or weakly expressed in benign lesions. CXCL12 stimulated the invasion and migration of K1 cells overexpressing CXCR4, but did not affect K1 cells overexpressing CXCR7. K1 cell proliferation was not affected by overexpression of CXCR4 or CXCR7. Overexpression of CXCR4 in K1 cells significantly increased AKT and ERK phosphorylation and markedly induced the expression and activity of matrix metalloproteinase-2 (MMP‑2). Thus, CXCL12 may be an effective diagnostic marker for papillary thyroid carcinoma, and CXCL12/CXCR4/CXCR7 axis may contribute to thyroid cancer development by regulating cancer cell migration and invasion via AKT and ERK signaling and MMP-2 activation.

Citing Articles

The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively.

Hu A, Tian J, Deng X, Wang Z, Li Y, Wang J Front Endocrinol (Lausanne). 2024; 15:1484838.

PMID: 39610843 PMC: 11602296. DOI: 10.3389/fendo.2024.1484838.

Diagnostic and prognostic utility of TROP-2, SLP-2, and CXCL12 expression in papillary thyroid carcinoma.

Attia A, Hussein S, Sameh H, Khalil A, Waley A, Matar I Cancer Biomark. 2023; 39(3):211-221.

PMID: 38073379 PMC: 11091596. DOI: 10.3233/CBM-230230.

New biomarkers: prospect for diagnosis and monitoring of thyroid disease.

Macvanin M, Gluvic Z, Zaric B, Essack M, Gao X, Isenovic E Front Endocrinol (Lausanne). 2023; 14:1218320.

PMID: 37547301 PMC: 10401601. DOI: 10.3389/fendo.2023.1218320.

Female Papillary Thyroid Cancer Survivors Are at Increased Risk of Adenomyosis and Endometrial Hyperplasia.

Tatarchuk T, Tronko M, Anagnostis P, Kalugina L, Pedachenko N, Danylova A Cureus. 2023; 15(5):e38989.

PMID: 37323314 PMC: 10261909. DOI: 10.7759/cureus.38989.

The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer.

Denaro N, Romano R, Alfieri S, Dolci A, Licitra L, Nuzzolese I Cancers (Basel). 2023; 15(9).

PMID: 37173925 PMC: 10177023. DOI: 10.3390/cancers15092458.

References

Lu C, Guo J, Gu J, Ge D, Hou Y, Lin Z . CXCR4 heterogeneous expression in esophageal squamous cell cancer and stronger metastatic potential with CXCR4-positive cancer cells. Dis Esophagus. 2013; 27(3):294-302. DOI: 10.1111/dote.12100. View

Sierro F, Biben C, Martinez-Munoz L, Mellado M, Ransohoff R, Li M . Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A. 2007; 104(37):14759-64. PMC: 1976222. DOI: 10.1073/pnas.0702229104. View

Balabanian K, Lagane B, Infantino S, Chow K, Harriague J, Moepps B . The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem. 2005; 280(42):35760-6. DOI: 10.1074/jbc.M508234200. View

Dambly-Chaudiere C, Cubedo N, Ghysen A . Control of cell migration in the development of the posterior lateral line: antagonistic interactions between the chemokine receptors CXCR4 and CXCR7/RDC1. BMC Dev Biol. 2007; 7:23. PMC: 1847803. DOI: 10.1186/1471-213X-7-23. View

Miao Z, Luker K, Summers B, Berahovich R, Bhojani M, Rehemtulla A . CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature. Proc Natl Acad Sci U S A. 2007; 104(40):15735-40. PMC: 1994579. DOI: 10.1073/pnas.0610444104. View

Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R . Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol. 2013; 2013:965212. PMC: 3664492. DOI: 10.1155/2013/965212. View

Ghosh M, Makena P, Gorantla V, Sinclair S, Waters C . CXCR4 regulates migration of lung alveolar epithelial cells through activation of Rac1 and matrix metalloproteinase-2. Am J Physiol Lung Cell Mol Physiol. 2012; 302(9):L846-56. PMC: 3362158. DOI: 10.1152/ajplung.00321.2011. View

Burns J, Summers B, Wang Y, Melikian A, Berahovich R, Miao Z . A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med. 2006; 203(9):2201-13. PMC: 2118398. DOI: 10.1084/jem.20052144. View

Wagner P, Moo T, Arora N, Liu Y, Zarnegar R, Scognamiglio T . The chemokine receptors CXCR4 and CCR7 are associated with tumor size and pathologic indicators of tumor aggressiveness in papillary thyroid carcinoma. Ann Surg Oncol. 2008; 15(10):2833-41. DOI: 10.1245/s10434-008-0064-2. View

10.

Yang L, Yuan Y, Sun T, Li H, Wang N . Population-based cancer incidence analysis in Beijing, 2008-2012. Chin J Cancer Res. 2015; 27(1):13-21. PMC: 4329184. DOI: 10.3978/j.issn.1000-9604.2015.01.07. View

11.

Kilfoy B, Zheng T, Holford T, Han X, Ward M, Sjodin A . International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control. 2008; 20(5):525-31. PMC: 2788231. DOI: 10.1007/s10552-008-9260-4. View

12.

Bleul C, Fuhlbrigge R, Casasnovas J, Aiuti A, Springer T . A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med. 1996; 184(3):1101-9. PMC: 2192798. DOI: 10.1084/jem.184.3.1101. View

13.

Wang J, Shiozawa Y, Wang J, Wang Y, Jung Y, Pienta K . The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem. 2007; 283(7):4283-94. DOI: 10.1074/jbc.M707465200. View

14.

Jung Y, Park I, Kim M, Min H, Won J, Ryu H . Application of chemokine CXC motif ligand 12 as a novel diagnostic marker in preoperative fine-needle aspiration biopsy for papillary thyroid carcinoma. Acta Cytol. 2013; 57(5):447-54. DOI: 10.1159/000351305. View

15.

Lu D, Tang C, Yeh W, Wong K, Lin C, Chen Y . SDF-1alpha up-regulates interleukin-6 through CXCR4, PI3K/Akt, ERK, and NF-kappaB-dependent pathway in microglia. Eur J Pharmacol. 2009; 613(1-3):146-54. DOI: 10.1016/j.ejphar.2009.03.001. View

16.

Chung S, Park E, Park S, Song J, Ryu H . CXC motif ligand 12 as a novel diagnostic marker for papillary thyroid carcinoma. Head Neck. 2013; 36(7):1005-12. DOI: 10.1002/hed.23404. View

17.

Sun Y, Schneider A, Jung Y, Wang J, Dai J, Wang J . Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res. 2005; 20(2):318-29. DOI: 10.1359/JBMR.041109. View

18.

De Falco V, Guarino V, Avilla E, Castellone M, Salerno P, Salvatore G . Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer. Cancer Res. 2007; 67(24):11821-9. DOI: 10.1158/0008-5472.CAN-07-0899. View

19.

Muller A, Homey B, Soto H, Ge N, CATRON D, Buchanan M . Involvement of chemokine receptors in breast cancer metastasis. Nature. 2001; 410(6824):50-6. DOI: 10.1038/35065016. View

20.

Liu Z, Sun D, Teng X, Xu W, Meng X, Wang B . Expression of stromal cell-derived factor 1 and CXCR7 in papillary thyroid carcinoma. Endocr Pathol. 2012; 23(4):247-53. DOI: 10.1007/s12022-012-9223-x. View